Under the Trump administration, the real estate sector will likely face new circumstances defined by deregulation, leadership changes and tax reforms. While reduced compliance costs and regulatory burdens might pose...more
11/7/2024
/ Advertising ,
Antitrust Provisions ,
Artificial Intelligence ,
Biometric Information ,
China ,
Corporate Taxes ,
Cybersecurity ,
Deregulation ,
Employment Policies ,
Environmental Policies ,
Environmental Social & Governance (ESG) ,
Facial Recognition Technology ,
Federal Trade Commission (FTC) ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Independent Contractors ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Investment ,
Joint Employers ,
NLRA ,
Non-Compete Agreements ,
Patents ,
Real Estate Market ,
Retail ,
Tariffs ,
Tax Cuts and Jobs Act ,
Tax Exemptions ,
Technology Sector ,
Tips ,
Tracking Systems ,
Unions ,
USPTO
With President-elect Trump announced as the winner of the 2024 election, the landscape of U.S. policy is poised for potential shifts that could significantly impact the life sciences sector. To a large degree, the extent to...more
11/7/2024
/ Antitrust Provisions ,
Bayh-Dole Act ,
Corporate Taxes ,
Drug Pricing ,
Employee Definition ,
Federal Trade Commission (FTC) ,
Independent Contractors ,
Inflation Reduction Act (IRA) ,
Intellectual Property Protection ,
Investment ,
Legislative Agendas ,
Life Sciences ,
NLRA ,
Non-Compete Agreements ,
SALT ,
Tariffs ,
Tax Cuts ,
Tax Cuts and Jobs Act ,
Unions ,
USPTO
While the 2024 election cycle may introduce temporary uncertainty, the convergence of positive economic trends such as waning inflation, anticipated interest rate cuts and cautious optimism for a soft landing suggests robust...more
As the 2024 election cycle unfolds, the landscape of U.S. policy is poised for potential shifts that could significantly impact various sectors. With the Biden-Harris administration's focus on lowering the cost of...more
The line between free speech and brand protection remains blurry after a February jury verdict in the NFT case of Hermès Int’l. v. Rothschild and the recent Supreme Court oral arguments in Jack Daniel’s Properties, Inc. v....more
The line between free speech and brand protection remains blurry after a February jury verdict in the NFT case of Hermès Int’l. v. Rothschild and the recent Supreme Court oral arguments in Jack Daniel’s Properties, Inc. v....more
The UK Court of Appeal has issued its judgment in one of the latest hearings in Neurim Pharmaceuticals v Generics (UK) relating to Neurim’s insomnia drug, Circadin. The Court of Appeal ruled that an exclusive licensee has...more
4/13/2022
/ Appeals ,
Corporate Counsel ,
Exclusivity ,
Intellectual Property Protection ,
IP License ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Standing ,
UK